Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group
Titel:
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group
Auteur:
Eichenauer, Dennis A Plütschow, Annette Kreissl, Stefanie Sökler, Martin Hellmuth, Johannes C Meissner, Julia Mathas, Stephan Topp, Max S Behringer, Karolin Klapper, Wolfram Kuhnert, Georg Dietlein, Markus Kobe, Carsten Fuchs, Michael Diehl, Volker Engert, Andreas Borchmann, Peter